Sage Therapeutics - The FDA has granted Fast Track Designation to SAGE-718.katrina4384Feb 26, 20220 min readUpdated: Mar 31, 2022
Prilenia has entered into a collaboration and license agreement with Ferrer for the commercialization and co-development of pridopidine in Europe and other select markets
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
Comentários